N.N. Petrov National Medical Research Center of Oncology
26
7
8
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
3.8%
1 terminated/withdrawn out of 26 trials
80.0%
-6.5% vs industry average
12%
3 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (26)
Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact
Role: collaborator
BrEto-TCL - Defining the Role of Brentuximab and Etoposide for Optimizing First-line Therapy of T-cell Lymphomas
Role: lead
High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors
Role: lead
ICG Fluorescence Guided Lymph Node Mapping for Determination of Bowel Resection Margins in Colon Cancer
Role: lead
Survival Monitoring in Russian Cancer Registries
Role: lead
Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas
Role: lead
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
Role: lead
Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer
Role: lead
Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations
Role: lead
Sentinel Lymph Node Biopsy in Stage AI-IIA Germ Cell Tumors
Role: lead
Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin Lymphoma
Role: collaborator
Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Rectal Resections for Cancer Versus MBP Alone
Role: lead
Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Colon Cancer Resections Versus no Bowel Preparation
Role: lead
Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB)
Role: lead
Multicentral Preventive Antibiotics With Cystectomy Within Enhanced Recovery After Surgery
Role: lead
Study of Oncological Outcomes of D3 Lymph Node Dissection in Colon Cancer
Role: lead
HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer
Role: lead
Clinical Validation of Cervical Cancer Screening Methods
Role: lead
Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer
Role: lead
Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation Therapy
Role: lead